UNICA IRIS Institutional Research Information System

CRISPONI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 178.059
NA - Nord America 12.172
AS - Asia 4.094
SA - Sud America 614
AF - Africa 64
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 195.021
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 173.806
US - Stati Uniti d'America 12.030
CN - Cina 1.753
SG - Singapore 1.688
UA - Ucraina 1.127
NL - Olanda 1.073
SE - Svezia 636
BR - Brasile 509
DE - Germania 486
GB - Regno Unito 317
FI - Finlandia 294
VN - Vietnam 180
KR - Corea 152
CA - Canada 104
FR - Francia 99
IN - India 80
RU - Federazione Russa 54
AR - Argentina 40
IR - Iran 33
ES - Italia 31
HK - Hong Kong 29
MX - Messico 28
JP - Giappone 26
TR - Turchia 26
BE - Belgio 25
IQ - Iraq 23
BD - Bangladesh 20
AT - Austria 19
PL - Polonia 19
EC - Ecuador 18
AU - Australia 15
ID - Indonesia 15
ZA - Sudafrica 15
CH - Svizzera 12
UY - Uruguay 12
EG - Egitto 9
IE - Irlanda 9
TN - Tunisia 9
UZ - Uzbekistan 9
PE - Perù 8
CL - Cile 7
CZ - Repubblica Ceca 7
MU - Mauritius 7
RO - Romania 7
CO - Colombia 6
NG - Nigeria 6
SA - Arabia Saudita 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
MA - Marocco 5
PT - Portogallo 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
DZ - Algeria 4
JO - Giordania 4
RS - Serbia 4
TH - Thailandia 4
AM - Armenia 3
AZ - Azerbaigian 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PH - Filippine 3
PK - Pakistan 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
MN - Mongolia 2
NO - Norvegia 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 195.015
Salva come PNG Salva come JPEG
Città #
Cagliari 170.462
Uta 2.568
Fairfield 1.439
Woodbridge 1.072
Amsterdam 1.054
Ashburn 963
Houston 804
Chandler 767
Singapore 712
Dallas 618
Wilmington 609
Jacksonville 606
Ann Arbor 597
Boardman 579
Seattle 554
Cambridge 508
Nyköping 439
Dearborn 295
Beijing 248
Nanjing 194
Hefei 183
Los Angeles 175
Boston 160
Seoul 145
Helsinki 113
Santa Clara 112
Buffalo 93
The Dalles 93
New York 92
Shanghai 88
San Diego 70
Escalaplano 69
Nanchang 69
Milan 63
Guangzhou 61
Ho Chi Minh City 57
Shenyang 56
Hebei 52
Redwood City 52
São Paulo 51
Tianjin 47
Changsha 46
Toronto 45
Jiaxing 43
Redondo Beach 39
Verona 36
Hanoi 35
Mountain View 34
Atlanta 33
Norwalk 33
Dong Ket 30
London 30
Hong Kong 29
Orange 29
Zhengzhou 29
Sassari 28
Jinan 26
Brussels 25
Ottawa 25
Council Bluffs 23
Ningbo 22
Tokyo 20
Chicago 19
Pune 18
Auburn Hills 17
Brooklyn 16
Cedar Knolls 16
Hangzhou 16
Pars 16
Nuremberg 15
Rio de Janeiro 15
Warsaw 15
Rome 14
San Jose 14
Washington 13
Bari 12
San Francisco 12
Stockholm 12
Turku 12
Columbus 11
Falls Church 11
Phoenix 11
Belo Horizonte 10
Curitiba 10
Fuzhou 10
Wuhan 10
Ankara 9
Charlotte 9
Jakarta 9
Padova 9
Chennai 8
Dublin 8
Frankfurt am Main 8
Johannesburg 8
Kunming 8
Montevideo 8
Redmond 8
Ribeirão Preto 8
Sinalunga 8
Spin 8
Totale 188.090
Salva come PNG Salva come JPEG
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.703
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.810
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.596
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.516
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.484
Multiple Sclerosis and environmental factors. 3.253
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.905
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.754
The essential metals for humans: a brief overview 2.663
Looking at new ligands for chelation therapy 2.513
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.398
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.376
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.263
Gold nanoparticles: A new golden Era in oncology? 2.234
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.199
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.181
Do anti-diabetic drugs act as copper ligands? 2.166
Toxicity of nanoparticles: etiology and mechanisms 2.132
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.072
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.034
Arsenic toxicity: Molecular targets and therapeutic agents 2.020
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.012
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 1.967
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.947
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.937
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.917
Kill or cure: Misuse of chelation therapy for human diseases 1.901
The meaning of aluminium exposure on human health and aluminium-related diseases 1.889
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.863
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.857
Silver coordination compounds: A new horizon in medicine 1.836
Alarming use of chelation therapy 1.824
Chemical features of in use and in progress chelators for iron overload 1.807
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.803
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.794
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.769
State of art in chelating agents for the clinical treatment of metal poisoning 1.769
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.763
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.750
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.730
Noble metals in medicine: Latest advances 1.714
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.700
Chelating agents as therapeutic compounds - Basic principles 1.689
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.679
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.631
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.612
Uneven hepatic copper distribution in Wilson's disease 1.581
Chelating agents for human diseases related to aluminium overload 1.541
Uneven cardiac iron distribution in beta-thalassemia 1.491
Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips 1.408
Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine 1.328
Chelating agents for metal intoxication 1.278
The Potential Clinical Properties of Magnesium 1.255
Metal ion toxicity 1.217
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.212
Iron chelating agents for iron overload diseases 1.209
null 1.188
Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology 1.184
Warns against unapproved ‘chelation therapy’ 1.168
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.133
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.124
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.119
null 1.075
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson’s disease and beta-thalassemia 1.069
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.065
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.047
A new hydroxypyrone chelating agent for FeIII and AlIII: a structural and equilibrium study 1.038
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 1.032
Sampling variability in hepatic iron concentration in beta-thalassemia 994
Kojic derivatives: a promising class of iron(III) chelators 976
Enhancement of g-aminobutyric acid binding by Quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors 946
A spectroscopic study on ionization of 2-, 3- and 4-aminopyridines 946
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 915
Chelating Agents in Soil Remediation: A New Method for a Pragmatic Choice of the Right Chelator 909
The outer/inner sphere dichotomy in the reaction of some adenine-like N-ligands with [Cu(H2EDTA)(H2O)] chelate 889
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 887
Aluminium dependent human diseases, and chelating properties of aluminium chelators for bio-medical applications 871
Nickel binding sites in histone proteins: spectroscopic and structural characterization 861
null 845
A Chemometric analysis of metal ion content in Sardinian wines 828
Manganese and cobalt binding in a multi-histidinic fragment 812
Preface 805
Anomalies of the oral cavity in newborns 783
Stress and ß-carbolines decrease the density of low affinity Gaba binding sites; an effect reversed by diazepam 757
Complex formation equilibria of copper(II) with triethylentetramine and its human acetyl metabolites 756
Calculation of spectra parameters in several spectra by contemporary decomposition in the constituent Gaussian peaks 729
Divalent metal-acetate complexes in concentrated aqueous solutions. An X-ray diffraction and NMR spectroscopy study 724
Structural correlations in nickel(II)-thiodiacetato complexes: molecular and crystal structures and properties of [Ni(tda)(H2O)(3)] 702
Changes in the characteristics of low affinity of Gaba binding sites elicited by Ro15-1788 700
SUBSTITUENT EFFECTS OF NITRO GROUP ON THE COMPLEX FORMATION EQUILIBRIA OF SALICYLIC ACID AND CATECHOL WITH Fe(III) AND Al(III) IONS 686
null 678
Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues 673
null 666
Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease 664
Thiodiacetato-copper(II) chelates with or without N-heterocyclic donor ligands: molecular and/or crystal structures of [Cu(tda)](n), [Cu(tda)(Him)(2)(H2O)] and [Cu(tda)(5Mphen)] center dot 2H(2)O (Him = imidazole, 5Mphen=5-methyl-1,10-phenanthroline) 662
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson and beta-thalassemia 662
Equilibrium constants of the Fe(III)dopamine system in aqueous solution 652
A windmill-shaped hexacopper(II) molecule built up by template core-controlled expansion of diaquatetrais(mu(2)-adeninato-N3,N9)dicopper(II) with aqua(oxydiacetato)copper(II) 651
Uneven element distribution in alcoholic liver disease. A case report 620
THIODIACETATE-COPPER(II) CHELATES WITH OR WITHOUT N-HETEROCYCLIC DONOR LIGANDS. CRYSTAL STRUCTURES OF [CU(TDA)]N, [CU(TDA)(HIM)2(H2O)] AND [CU(TDA)(5MPHEN)].2H2O 614
Totale 155.057
Salva come PNG Salva come JPEG
Categoria #
all - tutte 262.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122.414 0 0 0 0 0 6.362 4.999 3.278 1.210 2.699 2.162 1.704
2021/20228.541 1.083 959 497 772 751 678 521 326 596 687 881 790
2022/202311.356 922 1.154 1.175 826 942 1.268 548 1.937 802 571 719 492
2023/202412.856 746 532 575 997 1.394 2.210 1.777 829 517 1.068 1.120 1.091
2024/202528.715 7.253 7.466 3.352 2.552 1.431 1.515 2.380 203 420 1.370 319 454
2025/20264.115 563 379 1.242 736 530 665 0 0 0 0 0 0
Totale 195.438